Literature DB >> 29307543

Neurotensin speeds inhibition of dopamine neurons through temporal modulation of GABAA and GABAB receptor-mediated synaptic input.

Christopher W Tschumi1, Michael J Beckstead2.   

Abstract

Midbrain dopamine neurons play physiological roles in many processes including reward learning and motivated behavior, and are tonically inhibited by γ-aminobutyric acid (GABA)ergic input from multiple brain regions. Neurotensin (NT) is a neuropeptide which acutely modulates midbrain dopamine neuron excitability through multiple mechanisms, one of which is a decrease of GABA-mediated inhibition. However, the mechanisms through which NT depresses GABA signaling are not known. Here we used whole cell patch-clamp electrophysiology of dopamine neurons in mouse brain slices to show that NT acts both presynaptically to increase GABAA and postsynaptically to decrease GABAB receptor-mediated currents in the substantia nigra. The active peptide fragment NT8-13 enhanced GABAA signaling presynaptically by causing an increase in the size of the readily releasable pool of GABA via activation of the NT type-1 receptor and protein kinase A. Conversely, NT8-13 depressed GABAB signaling postsynaptically via the NT type-2 receptor in a process that was modulated by protein kinase C. Both forms of plasticity could be observed simultaneously in single dopamine neurons. Thus, as the kinetics of GABAA signaling are significantly faster than those of GABAB signaling, NT functionally speeds GABAergic input to midbrain dopamine neurons. This finding contributes to our understanding of how neuropeptide-induced plasticity can simultaneously differentiate and integrate signaling by a single neurotransmitter in a single cell and provides a basis for understanding how neuropeptides use temporal shifts in synaptic strength to encode information.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dopamine; GABA; Mouse; Neuropeptide; Neurotensin; Readily releasable pool; Substantia nigra

Mesh:

Substances:

Year:  2018        PMID: 29307543      PMCID: PMC6233987          DOI: 10.1016/j.neuropharm.2018.01.004

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  74 in total

1.  Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody.

Authors:  A Fassio; G Evans; R Grisshammer; J P Bolam; M Mimmack; P C Emson
Journal:  Neuropharmacology       Date:  2000-06-08       Impact factor: 5.250

2.  Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system.

Authors:  Philippe Sarret; Amélie Perron; Thomas Stroh; Alain Beaudet
Journal:  J Comp Neurol       Date:  2003-07-07       Impact factor: 3.215

3.  Circuit specificity in the inhibitory architecture of the VTA regulates cocaine-induced behavior.

Authors:  Nicholas J Edwards; Hugo A Tejeda; Marco Pignatelli; Shiliang Zhang; Ross A McDevitt; Jocelyn Wu; Caroline E Bass; Bernhard Bettler; Marisela Morales; Antonello Bonci
Journal:  Nat Neurosci       Date:  2017-01-23       Impact factor: 24.884

Review 4.  Neurotensin: A role in substance use disorder?

Authors:  Luca Ferraro; Laura Tiozzo Fasiolo; Sarah Beggiato; Andrea C Borelli; Lucyna Pomierny-Chamiolo; Malgorzata Frankowska; Tiziana Antonelli; Maria C Tomasini; Kjell Fuxe; Malgorzata Filip
Journal:  J Psychopharmacol       Date:  2016-01-11       Impact factor: 4.153

5.  CRF-R2 and the heterosynaptic regulation of VTA glutamate during reinstatement of cocaine seeking.

Authors:  Courtney L Williams; William C Buchta; Arthur C Riegel
Journal:  J Neurosci       Date:  2014-07-30       Impact factor: 6.167

Review 6.  Neurotensin and neurotensin receptors.

Authors:  J P Vincent; J Mazella; P Kitabgi
Journal:  Trends Pharmacol Sci       Date:  1999-07       Impact factor: 14.819

7.  Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia.

Authors:  Paul S Frankel; Amanda J Hoonakker; Mario E Alburges; Jacob W McDougall; Lisa M McFadden; Annette E Fleckenstein; Glen R Hanson
Journal:  J Pharmacol Exp Ther       Date:  2010-12-02       Impact factor: 4.030

8.  Hypothalamic neurotensin projections promote reward by enhancing glutamate transmission in the VTA.

Authors:  Kimberly A Kempadoo; Clara Tourino; Saemi L Cho; Francesco Magnani; Gina-Marie Leinninger; Garret D Stuber; Feng Zhang; Martin G Myers; Karl Deisseroth; Luis de Lecea; Antonello Bonci
Journal:  J Neurosci       Date:  2013-05-01       Impact factor: 6.167

9.  Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety.

Authors:  Larry S Zweifel; Jonathan P Fadok; Emmanuela Argilli; Michael G Garelick; Graham L Jones; Tavis M K Dickerson; James M Allen; Sheri J Y Mizumori; Antonello Bonci; Richard D Palmiter
Journal:  Nat Neurosci       Date:  2011-04-17       Impact factor: 24.884

10.  Presence of proNGF-sortilin signaling complex in nigral dopamine neurons and its variation in relation to aging, lactacystin and 6-OHDA insults.

Authors:  Yi Xia; Bei-Yu Chen; Xiao-Long Sun; Li Duan; Guo-Dong Gao; Jing-Jie Wang; Ken Kam-Lin Yung; Liang-Wei Chen
Journal:  Int J Mol Sci       Date:  2013-07-08       Impact factor: 5.923

View more
  5 in total

Review 1.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

2.  Diverse actions of the modulatory peptide neurotensin on central synaptic transmission.

Authors:  Christopher W Tschumi; Michael J Beckstead
Journal:  Eur J Neurosci       Date:  2018-02-28       Impact factor: 3.386

3.  Neurotensin Release from Dopamine Neurons Drives Long-Term Depression of Substantia Nigra Dopamine Signaling.

Authors:  Christopher W Tschumi; Harris E Blankenship; Ramaswamy Sharma; William B Lynch; Michael J Beckstead
Journal:  J Neurosci       Date:  2022-07-06       Impact factor: 6.709

4.  Analysis of the Underlying Mechanism of the Jiu Wei Zhen Xin Formula for Treating Generalized Anxiety Disorder Based on Network Pharmacology of Traditional Chinese Medicine.

Authors:  Heng Shao; Quan Gan; Zhuangfei Chen; Shasha Zhu; Yanqing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-29       Impact factor: 2.650

Review 5.  Study on the Correlation Between NF-κB and Central Fatigue.

Authors:  Xingzhe Yang; Feng Li; Yan Liu; Danxi Li; Jie Li
Journal:  J Mol Neurosci       Date:  2021-02-14       Impact factor: 3.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.